SomniCheck

FDA 510(k) K223676 · Brainmatterz, LLC

Substantially Equivalent

510(k) numberK223676

Submission

Device name
SomniCheck
Applicant
Brainmatterz, LLC
Richmond, TX, US
Received
December 8, 2022
Decision date
June 1, 2023
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
GWL – Amplifier, Physiological Signal
Device class
Class II (moderate risk)
Regulation
21 CFR 882.1835
Specialty
Neurology

Other 510(k)s with product code GWL

510(k)DeviceApplicantDecision
K243746Delphi AmplifierGWL · Traditional Quantalx Neroscience03/12/2025SE
K242832NExT Station; NExT Station AdvancedGWL · Special Eb Neuro S.P.A.12/12/2024SE
K242305BE Plus PRO, Neurotravel LIGHTGWL · Special Eb Neuro S.P.A.09/04/2024SE
K240646DreamClearGWL · Traditional Somnomed Technologies Inc., Doing Business AS…09/04/2024SE
K232210X-trodes System MGWL · Traditional X-Trodes02/04/2024SE
K230148VlabGWL · Traditional Dormotech Medical, Ltd.10/11/2023SE
K220631NomadAir PMU810GWL · Traditional Neurotronics, Inc.07/15/2022SE
K203331Quick-20mGWL · Traditional Cgx, LLC05/20/2021SE
K202174Digital NeuroPort Biopotential Signal Processing SystemGWL · Special Blackrock Microsystems02/10/2021SE
K2017478-CH Electroencephalography AmplifierGWL · Traditional Hipposcreen Neurotech Corp.12/27/2020SE

Questions and answers

When was SomniCheck cleared by the FDA?

SomniCheck (K223676) received a 510(k) decision of Substantially Equivalent on June 1, 2023, 175 days after the submission was received.

What is the product code of K223676?

The FDA product code is GWL – Amplifier, Physiological Signal, a Class II (moderate risk) device regulated under 21 CFR 882.1835.